Deka Bank Deutsche Girozentrale Rigel Pharmaceuticals Inc Transaction History

Deka Bank Deutsche Girozentrale

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$2.36 - $3.57 $117,056 - $177,072	-49,600 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$1.78 - $4.13 $88,288 - $204,848	49,600 New	49,600 $111,000
Q4 2019 Feb 04, 2020	SELL	$1.6 - $2.43 $81,600 - $123,930	-51,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.63 - $2.62 $83,130 - $133,620	-51,000 Reduced 50.0%	51,000 $93,000
Q2 2019 Aug 01, 2019	BUY	$2.02 - $2.61 $79,790 - $103,095	39,500 Added 63.2%	102,000 $250,000
Q1 2019 May 10, 2019	BUY	$2.0 - $2.65 $23,000 - $30,475	11,500 Added 22.55%	62,500 $207,000
Q4 2018 Feb 12, 2019	SELL	$2.08 - $3.36 $23,920 - $38,640	-11,500 Reduced 18.4%	51,000 $114,000
Q1 2018 May 03, 2018	BUY	$3.54 - $4.54 $221,250 - $283,750	62,500 New	62,500 $232,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $4.61B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.